These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A single photon emission computed tomography scan study of striatal dopamine D2 receptor binding with 123I-epidepride in patients with schizophrenia and controls. Tibbo P; Silverstone PH; McEwan AJ; Scott J; Joshua A; Golberg K J Psychiatry Neurosci; 1997 Jan; 22(1):39-45. PubMed ID: 9002391 [TBL] [Abstract][Full Text] [Related]
6. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics. Klemm E; Grünwald F; Kasper S; Menzel C; Broich K; Danos P; Reichmann K; Krappel C; Rieker O; Briele B; Hotze AL; Möller HJ; Biersack HJ Am J Psychiatry; 1996 Feb; 153(2):183-90. PubMed ID: 8561197 [TBL] [Abstract][Full Text] [Related]
7. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Kegeles LS; Abi-Dargham A; Zea-Ponce Y; Rodenhiser-Hill J; Mann JJ; Van Heertum RL; Cooper TB; Carlsson A; Laruelle M Biol Psychiatry; 2000 Oct; 48(7):627-40. PubMed ID: 11032974 [TBL] [Abstract][Full Text] [Related]
8. Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects. Abi-Dargham A; van de Giessen E; Slifstein M; Kegeles LS; Laruelle M Biol Psychiatry; 2009 Jun; 65(12):1091-3. PubMed ID: 19167701 [TBL] [Abstract][Full Text] [Related]
9. SPECT imaging of striatal dopamine release after amphetamine challenge. Laruelle M; Abi-Dargham A; van Dyck CH; Rosenblatt W; Zea-Ponce Y; Zoghbi SS; Baldwin RM; Charney DS; Hoffer PB; Kung HF J Nucl Med; 1995 Jul; 36(7):1182-90. PubMed ID: 7790942 [TBL] [Abstract][Full Text] [Related]
10. Dopaminergic neurotransmission in patients with schizophrenia in relation to positive and negative symptoms. Pogarell O; Koch W; Karch S; Dehning S; Müller N; Tatsch K; Poepperl G; Möller HJ Pharmacopsychiatry; 2012 May; 45 Suppl 1():S36-41. PubMed ID: 22565233 [TBL] [Abstract][Full Text] [Related]
11. Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression. Parsey RV; Oquendo MA; Zea-Ponce Y; Rodenhiser J; Kegeles LS; Pratap M; Cooper TB; Van Heertum R; Mann JJ; Laruelle M Biol Psychiatry; 2001 Sep; 50(5):313-22. PubMed ID: 11543733 [TBL] [Abstract][Full Text] [Related]
12. Increased release of dopamine in the striata of young adults with hearing impairment and its relevance for the social defeat hypothesis of schizophrenia. Gevonden M; Booij J; van den Brink W; Heijtel D; van Os J; Selten JP JAMA Psychiatry; 2014 Dec; 71(12):1364-72. PubMed ID: 25271822 [TBL] [Abstract][Full Text] [Related]
13. Striatal dopamine D2 receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an 123I-IBZM-SPECT study. Lomeña F; Catafau AM; Parellada E; Bernardo M; Font M; Gutiérrez F; Pavía J Psychopharmacology (Berl); 2004 Mar; 172(2):165-9. PubMed ID: 14624330 [TBL] [Abstract][Full Text] [Related]
14. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates. Innis RB; Malison RT; al-Tikriti M; Hoffer PB; Sybirska EH; Seibyl JP; Zoghbi SS; Baldwin RM; Laruelle M; Smith EO Synapse; 1992 Mar; 10(3):177-84. PubMed ID: 1532675 [TBL] [Abstract][Full Text] [Related]
15. Gender differences in D2 dopamine receptor binding in drug-naive patients with schizophrenia: an [123I]iodobenzamide single photon emission computed tomography study. Schröder J; Bubeck B; Silvestri S; Demisch S; Sauer H Psychiatry Res; 1997 Sep; 75(2):115-23. PubMed ID: 9351493 [TBL] [Abstract][Full Text] [Related]
16. Striatal dopamine release in schizophrenia comorbid with substance dependence. Thompson JL; Urban N; Slifstein M; Xu X; Kegeles LS; Girgis RR; Beckerman Y; Harkavy-Friedman JM; Gil R; Abi-Dargham A Mol Psychiatry; 2013 Aug; 18(8):909-15. PubMed ID: 22869037 [TBL] [Abstract][Full Text] [Related]
17. Amphetamine-Induced Striatal Dopamine Release Measured With an Agonist Radiotracer in Schizophrenia. Frankle WG; Paris J; Himes M; Mason NS; Mathis CA; Narendran R Biol Psychiatry; 2018 Apr; 83(8):707-714. PubMed ID: 29325847 [TBL] [Abstract][Full Text] [Related]
18. Increase of striatal dopamine transmission in first episode drug-naive schizophrenic patients as demonstrated by [(123)I]IBZM SPECT. Schmitt GJ; Meisenzahl EM; Frodl T; La Fougère C; Hahn K; Möller HJ; Dresel S Psychiatry Res; 2009 Sep; 173(3):183-9. PubMed ID: 19683898 [TBL] [Abstract][Full Text] [Related]
19. Dual-isotope SPECT imaging of striatal dopamine: first episode, drug naïve schizophrenic patients. Schmitt GJ; la Fougère C; Dresel S; Frodl T; Hahn K; Möller HJ; Meisenzahl EM Schizophr Res; 2008 Apr; 101(1-3):133-41. PubMed ID: 18083348 [TBL] [Abstract][Full Text] [Related]
20. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Kegeles LS; Abi-Dargham A; Frankle WG; Gil R; Cooper TB; Slifstein M; Hwang DR; Huang Y; Haber SN; Laruelle M Arch Gen Psychiatry; 2010 Mar; 67(3):231-9. PubMed ID: 20194823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]